Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Autor: | Fassnacht, Martin, Berruti, Alfredo, Baudin, Eric, Demeure, Michael J, Gilbert, Jill, Haak, Harm, Kroiss, Matthias, Quinn, David I, Hesseltine, Elizabeth, Ronchi, Cristina L, Terzolo, Massimo, Choueiri, Toni K, Poondru, Srinivasu, Fleege, Tanya, Rorig, Ramona, Chen, Jihong, Stephens, Andrew W, Worden, Francis, Hammer, Gary D |
---|---|
Zdroj: | In The Lancet Oncology April 2015 16(4):426-435 |
Databáze: | ScienceDirect |
Externí odkaz: |